
Company Information
Ask for more detail from the seller
Contact Supplier| cas: | 1715016-76-4 |
| formula: | c21h22fn3o3 |
| molecular weight: | 383.16 |
| compound purity: | > 99.7% |
| appearance: | powder |
| iupac: | methyl (2s)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3-methylbutanoate |
amb-fubinaca (also known as fub-amb and mmb-fubinaca) is an indazole-based synthetic cannabinoid that is a potent agonist of the cb1 receptor and has been sold online as a designer drug.
it was originally developed by pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.
identifiers
iupac name: methyl (2s)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3-methylbutanoate
cas number: 1715016-76-4
pubchem cid: 119026173
chemspider: 32741679
unii: ty9aki870r
chemical and physical data
formula: c21h22fn3o3
molar mass: 383.42 g/mol